INTRODUCTION
In the past few decades, the applications of NPs have expanded exponentially in different fields such as food, agriculture and medical (Barkalina et al; 2014, Grobe et al; 2012) . In the biomedical field, NPs show great potential as an anti-infective agent (Seil et al; 2012) , in the delivery of drug and vaccine molecules (Mahapatro et al; 2011) , for imaging and cell tracking, and in disease diagnostics (El-Sayed et al; 2005) . NPs, in particular, metallic NPs, are considered as potential alternatives to conventional antibiotics due to their ability to penetrate and immunomodulate the functions of cells efficiently (Joseph et al; 2013) and to kill drug-resistant microorganisms by a unique mode of action (Mocan et al; 2014) .
According to recent research, over 1000 different manufactured NPs were developed and introduced to the market (Chatterjee, 2008) . Some of them, after being applied may cause adverse effects on animal health and environment. Therefore, it becomes necessary to consider not only their usefulness but also the potential toxicity risks. In this context, NP toxicity refers to the ability of the particles to adversely affect the normal physiology as well as to directly interrupt the architecture and function of cells and tissues of human and animals. It is well accepted that cellular toxicity depends on various factors such as size, shape, stability, mode of synthesis and surface chemistry of NPs (Ekkapongpisit et al; 2012; Verma et al; 2010) . The emerging data suggest that cytotoxicity is caused by induction of oxidative stress (Manke et al; 2013) , hyperinflammation due to over activation of proinflammatory genes, the disintegration of cellular components (Sayes et al; 2006) , and activation of cell death pathways (De Stefano et al; 2012) . Other nanocytotoxicity parameters include administered dose, route of administration and extent of tissue distribution. Cellbased toxicity studies include the use of increasing doses of NP to observe dose-dependent toxicity, metabolic activities and maintenance of cellular integrity. Such dose and cellular response correlations are the bases for determining safe limits of particle concentrations for in vivo administration for the treatment of various diseases. It is sensible to assume that biodistribution, accumulation, metabolism, and excretion of NPs will differ depending on the route of administration. Therefore, studies on NP toxicological assessment are necessary to avoid detrimental adverse effects.
Among the metal oxide NPs, zinc oxide (ZnO) has received considerable attention. This is due to their low production cost, ability to form diverse structures and various biological applications including drug delivery, bioimaging probes, cancer treatment, antibacterial, and immunomodulatory agent (Hanley et al; 2008; Premanathan et al; 2011; Xiong, 2013) . Moreover, ZnO-NPs are listed safe by the U.S. Food and Drug Administration (21CFR182.8991). These broad applications led to increased exposure of ZnO-NPs to the environment and human being through either direct contact or inhalation. Previous studies have shown that specific doses of starch and chitosan-capped silver NPs can be used as antibacterial agents against human pathogens without causing significant harm to the human cells (de Oliveira et al; 2013; Jena et al; 2012; Mohanty et al; 2012) . Recently, it has been shown that topical application of ZnO-NPs can be used in the treatment of skin infections caused by Staphylococcus aureus in mice model (Pati et al; 2014) . With increasing interest to their potential toxicity, adverse effects of ZnO-NPs have been studied in vivo (AdamcakovaDodd et al; 2014; Sayes et al; 2007) , and in vitro (Lenz et al; 2013; Yang et al; 2009) .
However, despite the growing applications, the information about biological effects of ZnONPs is still insufficient and often controversial. Of note, the majority of studies have been conducted by culturing the animal cells under in vitro conditions. These in vitro models cannot replicate the intact in vivo system and various cellular interactions present in the body.
Hence, in vitro models fall short of accurately predicting the toxicological behaviour of the NPs in living organisms. Therefore, it is important to investigate the in vivo activities of ZnONPs before propagating their therapeutic potential using suitable animal models.
Peripheral blood mononuclear cells (consist of monocytes, macrophages, and lymphocytes) and bone marrow cells (comprised of red blood cells, platelets, and white blood cells) form a critical component of an immune system to fight infections and adapt to intruders (Parkin et al; 2001) . Many reports using in vitro systems indicate that the mechanism of ZnO toxicity involves the generation of reactive oxygen species (ROS) (Xia et al; 2008, Yang et al; 2009) . Some report that dissolution of ZnO, which is enhanced for the smallest particles (Mudunkotuwa et al; 2012) plays an important role in the toxicity mechanism of ZnO-NPs (Xia et al; 2008) . Exposure to ZnO-NPs is also known to induce autophagy (Yu et al; 2013) and DNA damage through lipid peroxidation and oxidative stress (Sharma et al; 2009 ).
Actin is the major cytoskeleton protein in eukaryotic cells participating in diverse cellular and physical processes, ranging from cell adhesion, migration, and division (Richard et al; 1999) . Owing to its central role in the cell, the actin cytoskeleton is also disrupted or taken over by numerous pathogens. Disruption of F-actin not only inhibits the phagocytic process but also trafficking and maturation of cellular organelles that are required for clearance of pathogenic materials (DeFife et al; 1999) . Previously it was reported that NPs target and degrade filamentous actin due to Ca2þ influx mediated by cavitation and perforation of the cell membrane (Tong et al; 2007) . Further gold NPs induced cytoskeleton filament disruption in human dermal fibroblast cells resulting in cell area contraction and cell migration (Mironava et al; 2010) .
In aerobic cells, ROS are generated as a by-product of normal mitochondrial activity.
If produced in excess ROS can cause severe damage to cellular macromolecules, especially DNA. The extent of DNA damage determines cell fate by cell cycle arrest, DNA repair or the activation of apoptotic pathways. Furthermore, DNA damage regarding chromosomal breakage, micronuclei formation, comet tail formation may also be related to the ZnO-NP induced ROS in treated cells. So far, over 100 genes have been found in human cells that are involved in 5 major DNA damage repair pathways (Wood et al; 2005) . Several studies have independently demonstrated the cytotoxic effects of ZnO-NPs in these cells under in vitro conditions (Yang et al; 2009; Song et al; 2010) . However, the mechanisms by which ZnONPs cause cellular toxicity under in vivo conditions are not well understood and no experimental data have been published on the in vivo genotoxic or clastogenic potential of ZnO-NPs.
In the previous chapter, the synthesis and characterization of ZnO-NPs were described (Pati et al; 2014) . The objective of the work presented in this study was to delineate the toxic effects of ZnO-NPs and to understand the mechanism of toxicity. We studied different in vitro and in vivo toxicological mechanisms of these ZnO-NPs using mouse macrophage cells and a mouse model. High-dose of ZnO-NPs reduced cell viability, prevented cell migration, and irreversibly disintegrated actin structure and actin polymerization process. Cell death pathway studies showed that ZnO-NPs markedly induced apoptosis, autophagy, and DNA damage by inducing DNA breaks, micronuclei formation, chromosomal disintegration, cellular protrusions, and downregulated the expression of DNA repair proteins in treated macrophages. Moreover, treatment with Nacetyl cysteine (NAC) after ZnO-NP exposure resulted in reduced genotoxicity, clastogenic and also upregulated the expression of DNA repair genes. A significant increase in the oxidative stress responses was observed by inhibiting oxygen radical scavenging activities of superoxide dismutase (SOD) and catalase enzymes. 
MATERIALS AND METHODS

Ethics Statement
Synthesis of ZnO-NPs
ZnO-NPs were synthesized by wet chemical method using zinc nitrate and sodium hydroxide (NaOH) as precursors and soluble starch as stabilizing agent (Pati et al; 2014) . 0.1 M of zinc nitrate was dissolved in 100 ml of 0.5% starch solution. After complete dissolution of zinc nitrate, equal volume of 0.2 M of NaOH solution was added slowly under constant stirring for 2 h. The solution was allowed to settle overnight, centrifuged at 10,000 g for 10 min and washed thrice with distilled water to remove the byproducts and excessive starch. After washing, ZnO-NPs were sonicated for 10 min in sterile water.
Cytotoxicity Assay
Mouse macrophage RAW 264.7 (1X10 3 cells/well) were grown in 96-well plates at 37̊ C, 5%
CO2 for 24h and then treated with different doses of ZnO-NP (0-100 µg/ml) and incubated for 24 h. Cell viability was determined by Calcein-AM and MTT assays as described previously (Grieshaber et al; 2010; Mohanty et al; 2012) .
Cell Migration Assay
Migratory activities of mouse macrophages in presence and absence of ZnO-NPs were observed by wound healing assay. Confluent monolayers of cultured cells were scrapped with a plastic tip to create a wound and then incubated with different concentrations of ZnO-NPs.
The healing of this wound gap was monitored for next 48 h. were treated with 60 and 100 mg/ml doses of ZnO-NPs and incubated for 24h. Untreated cells were used as the control. After the incubation, media was removed; cells were harvested and incubated with 5 µg/ml of DHE in 1XPBS for 10 min. For H2O2 estimation, after 24h of treatment 10 µM DCFH-DA was added to the cells and incubated at 37̊ C and 5% CO2 for 4h.
Then the DCFH-DA containing medium was removed, and the cells were rinsed with 1XPBS, the fluorescence intensity of both DHE and DCF was read in flow cytometer using BD FACS Canto-II and FACS Diva software using specific filter.
Catalase assay
Macrophages (1X10 6 ) were treated with ZnO-NPs as described earlier. was added to each well in a microtiter plate. The absorbance was immediately measured at 240nm every 10 s for 5 min at 22̊ C. Catalase activity was calculated based on the rate of decomposition of H2O2, which is proportional to the reduction of the absorbance at 240 nm.
SOD assay
SOD has superoxide radicals scavenging activity, which helps in the conversion of O2 ̅ to
H2O2. An assay method was developed where superoxide radicals were generated by the photo reduction of riboflavin. Briefly, a cocktail was prepared to a final concentration of 80mM of Tris buffer of pH 8.0, 1mM L-methionine, 1% Triton-X-100, 0.5 mM of hydroxylamine hydrochloride and 7 mM of EDTA. Negative control tube contains cocktail and 4mM of riboflavin, whereas sample tube contains SOD cocktail, riboflavin, and 80 µg of proteins prepared from untreated, ZnO-NP and zymosan (200 µg/ml) treated macrophages.
After addition of proteins from different samples in respective tubes, solutions were mixed properly and were exposed to 220 W white bulb to start the reaction for ten min. The O2 ̅ produced from riboflavin, will react to the nitric oxide (NO), and forms peroxynitrite that can be quantified by adding an equal volume of Griess reagent (1% sulfanilamide and 0.1% naphthylethylenediamine dihydrochloride in 5% concentrated H3PO4) and the color formed were measured at 540 nm. The intensity of colour is inversely proportional to the level of sodium dismutase in the sample.
Apoptosis Assay
The percentage of apoptotic cells was determined by using an Annexin V-FITC apoptosis detection kit (Sigma). Briefly, 2 ×10 5 RAW264.7 cells were grown overnight in a six-well culture plate, treated with various concentration of ZnO-NPs and the cells were incubated for another 24 h. The cells were treated with trypsin and washed three times with Dulbecco's phosphate buffer saline (0.1 M, pH 7.4). 500 µl of 1X binding buffer was added, followed by 5 µl of Annexin V-FITC and 10 µl of propidium iodide, and then incubated for 10 min at room temperature in the dark. Untreated cells were taken as a negative control. Flow cytometry was performed by analyzing 10,000 gated cells using a FACS Calibur flow cytometer and Cell Quest software (Becton Dickinson, USA).
Autophagy detection with acridine orange staining
As a marker of autophagy, the volume of the cellular acidic compartment was visualized by acridine orange staining (Krolenko et al; 2006) . Cells were seeded in 24 well plates on glass coverslides and treated with 60 and 75 µg/ml of ZnO-NPs and incubated for 24 h. After the appropriate time point following treatment, cells were incubated with medium containing 1µg/ml acridine orange (Hi-Media) for 30 minutes. The acridine orange was removed, washed with 1X PBS and mounted by using mounting solution (Invitrogen). Fluorescent micrographs were taken using fluorescent microscope.
Mice Treatment
Six-to eight-week old BALB/C mice were used for all experiments. All mice were kept in the department animal facility, in high efficiency particulate air filter bearing cages under 12 h light cycles, and were given sterile chow and autoclaved water ad libitum. All animal experiments were performed in accordance with national guidelines for the care and handling of laboratory animals and have been approved by the Institutional Animal Ethical Committee.
ZnO-NPs were dispersed in water by vortex mixing. Following experimental conditions were used: Group-I mice were administered with sterile water only (control). Group-II and Group-III mice were dosed with 200 and 500 mg/kg bodyweight of ZnO-NPs, respectively. Group-IV mice were dosed with 500 mg/kg bodyweight of ZnO-NPs and 100 mg/kg of body weight NAC as antioxidant drug daily by oral gavage.
Blood and Bone Marrow cell isolation
Peripheral blood was drawn from both control and treated mice via the sub-mandibular vein bleeding and collected into EDTA containing tubes. Bone marrow samples were collected after 6 days of treatment. Both femora were dissected, and bone marrow cells were flushed out with 1XPBS using 26-gauge needle. The cells were centrifuged at 250 rpm to remove muscle cells and other debris. The collected supernatants were again centrifuged at 1000rpm
for 5 min and the cells were resuspended into 1XPBS.
Blood Cell Count
Peripheral blood cells were isolated from mice as described earlier. A 3 µl of cell suspension was smeared onto a microscopic slide, stained with Giemsa (Hi-media) and the cells were observed under the microscope. The number of neutrophils, eosinophils, and lymphocytes were counted.
Micronucleus Assay
Micronucleus assay measures the DNA damage resulting from exposure to toxic agents (Fenech; 2006) . The in vivo micronuclei assay was performed in erythrocytes isolated from peripheral blood and bone marrow obtained from ZnO-NP, ZnO-NP with NAC treated and control mice as described previously (Kovvuru et al; 2014) . Briefly, 3 μl of peripheral blood and bone marrow cell suspensions were smeared onto microscopic slides and stained with Giemsa (Hi-media). At least 100 peripheral blood erythrocytes and bone marrow cells were analyzed per mouse in a blinded fashion using a 100Xobjective. The percentage of micronucleated cells were calculated in all the experimental conditions. In vitro cytokinesisblocked micronucleus assay was performed by treating the mouse macrophages with 60, 75, and 100 μg/ml doses of ZnO-NPs, and 100 µg/ml ZnO-NPs plus 5 mM NAC for 24 h. Then the cells were treated with cytochalasin B (8 µg/ml) (MP-BIOMEDICALS) and were incubated for another 22 h. Cells were harvested, centrifuged and the pellet was fixed with fixative (3:1 methanol/acetic acid). The cells were kept at 4̊ C for at least 4 days, added drop wise on glass slides and dried. The slides were then stained with propidium iodide (4 µg/ml) and analyzed by fluorescence microscopy to visualize bi-nucleated and micronuclei forming cells.
Comet Assay
The alkaline comet assay was performed to check the effect of ZnO-NP treatment on DNA damage. Macrophages were treated with ZnO-NP (60, 100 µg/ml) and 100 µg/ml ZnO-NPs +NAC for 24h at 37̊ C in an atmosphere of 5% CO2. Untreated cells were used as a control.
Cell suspensions (400 ml) were mixed with 1% low-melting point agarose (1 ml) and added to glass cavity slides (Blue Label Scientifics Pvt. Ltd, Mumbai, India). The agarose was allowed to solidify and then the slides were submerged in lysis solution (1.2 M sodium chloride, 100 mM EDTA disodium salt, 0.1% SDS, 0.26 M NaOH [pH . 13]) for 2h at 4̊ C in the dark. After lysis, the slides were washed with dH2O, transferred to an electrophoresis unit, covered with freshly prepared electrophoresis buffer (0.03 M NaOH, 2 mM EDTA disodium salt, pH 12.3), left for unwinding of DNA for 30 min, and the cells were electrophoresed for 22min at 22 V. The cells were neutralized with neutralization buffer (500mM Tris-HCl, pH 8.0) for 15 min, washed 3-4 times with dH2O, and stained with PI (4 µg/ml) for 1h. The slides were dried and then observed using the fluorescence microscope.
Karyotype Analysis
Genome instability is associated with defective segregation of chromosomes. Macrophages were treated with 60 and 100 µg/ml of ZnO-NPs alone and 100 µg/ml of ZnO-NPs +NAC for 24 h. Untreated cells were used as the control. Chromosomal assay was performed as reported earlier (Kadaja et al; 2009) . Briefly, after treatment cells were fixed with colchicines
(1 µg/ml) for metaphase arrest. Metaphasic chromosomes were prepared, stained with DAPI and scored for segregation defects. BX61 Olympus Microscope with Cytovision Software7.2 was used for the chromosomal analysis.
Measurement of Filamentous Actin by rhodamine-Phalloidin Fluorescence Assay
Macrophage cells (3X10 5 ) were cultured in 24-well cell culture plate for 24 h and then treated with 60, 75, 100 µg/ml concentrations of ZnO-NPs and 100 µg/ml of ZnO-NPs with NAC followed by incubated for another 24 h. After the incubation, cells were harvested and collected by centrifugation at 500 rpm. Then the cells were washed with 1XPBS and fixed with 3.7% paraformaldehyde in PBS for 10 min at RT. Cells were again washed with PBS and incubated with rhodamine-labeled phalloidin in PBS containing 0.5% bovine serum albumin (BSA) and 0.5 mg/ml saponin for 1h at RT. Afterward, cells were washed with PBS containing 0.5mg/ml saponin and bound rhodamine-labeled phalloidin was extracted with methanol over night at -20̊ C. Fluorescence intensity of the samples was measured in the Fluorescence Reader Synergy 4 (Perkin Elmer, USA) at 544nm (excitation) and 590nm (emission). Fluorescence intensity of ZnO-NP treated cells was given relative to the fluorescence intensity of non-treated cells.
Immunocytochemistry
Macrophages were seeded onto cover slides and treated with different concentrations of ZnONPs. Cells were fixed with 3.7% paraformaldehyde in 1XPBS for 10 min at RT. The samples were washed with 1XPBS and incubated with 0.1% triton-X-100 for 5 min followed by 20 min incubation with 5% BSA in 1XPBS at RT. Rhodamine-conjugated phalloidin solution was diluted 25 times in PBS and samples were incubated for 1h at RT. Cover slides were again washed with 1XPBS and mounted by DAPI containing the mounting solution (Invitrogen). Cells were analyzed by fluorescence microscopy (Olympus, USA).
Immunofluoroscence
The γH2AX 
Cell Cycle Analysis
After treatment with ZnO-NPs for 24 h, the cells were collected by centrifugation at 1500 rpm for 5 min and washed with ice cold phosphate buffered saline, stained with propidium iodide and ribonuclease for 30 min. The Cell cycle was analyzed by FACS Calibur flow cytometer (BD, USA).
Histopathological Examination
For histopathological studies, the respective organ specimens were removed immediately after the mice were sacrificed and fixed in phosphate buffer (pH 7.4) containing 4% formalin.
The formalin fixed biopsy specimens were embedded in paraffin, sections were prepared and stained with hematoxylin and eosin.
Western Blot
To check the expression of PARP, LC3 II, pol β, fen 1, β-actin, β-tubulin, and GAPDH macrophages were treated with indicated concentrations of ZnO-NPs for 24 h. Cells were harvested at different time points and centrifuged at 2000 rpm for 5 min and washed twice with 1XPBS. Protein samples were prepared by cell lysis using 1XSDS sample buffer (62.5mM Tris-HCL, pH 6.8, 2% w/v SDS, 10% glycerol, 50 mM DTT, 0.15 w/v bromophenol blue) supplemented with protease inhibitor cocktail and PMSF. Proteins were electrophoresed in 12% SDS-PAGE and transferred to PVDF membrane overnight at 28 V.
Then the blots were blocked using 5% BSA or 5% skim milk in 1XTris buffer saline and 1%
Tween 20 (TBST) for 10 h at 4̊ C. Then membranes were incubated with primary rabbit IgG antibodies (dilution 1:1000) overnight at 4̊ C. Next day, the membranes were washed 3 times using 1XTBST for 5 min. Then membranes were incubated with secondary goat anti-rabbit antibodies (1:1000) for 2h. The membrane was washed using 1XTBST, and X-ray film was developed using standard chemiluminescent solvent.
Mitochondrial membrane potential analysis
To analyze the mitochondrial membrane potential, macrophages were cultured on glass cover slides followed by the treatment with 60, 75 and 100 µg/ml doses of ZnO-NPs for 24 h.
Untreated cells were used as control. After the incubation period, the cells were washed with PBS and labelled with 10 nM concentration of Mito-tracker red at 37 0 C for 20 minutes.
Labelled cells were washed twice in fresh media and observed by fluorescence microscope (Olympus, USA).
Statistical Analysis
Significant differences between the groups were determined by 1-and 2-way ANOVA. All the statistical calculations were performed with the help of Graph Pad Prism version 5.0.
Significance was indicated as *** for P < .001; ** for P < .01 and *for P < .05.
RESULTS
Characterization of ZnO-NPs
In the previous chapter, the synthesis and characterization of starch capped ZnO-NPs have been described in detail (Pati et al; 2014) . The TEM micrograph showed the spherical shape NPs (Fig 4.1, A) . The XRD patterns of bulk ZnO and ZnO-NPs are represented in Fig 4. 1, B.
All the peaks could be indexed to hexagonal ZnO and were close to the reported data (JCPDS 79-0208; a=3.264 A , c=5.219 A ). In case of bulk ZnO sharp peaks were observed; however, when it is converted to ZnO-NPs the width of the peaks increased at the angle of 31.61 ̊ (100), 34.33 ̊ (002), and 36.10 ̊ (101). The starch peak was observed at the angle of 22.53 . In the previous chapter, it has been shown that treatment with lower doses of ZnO-NPs reduce bacterial skin infection in mice and also kill intracellular bacteria by inducing oxidative stress response in macrophages (Pati et al; 2014) . However, this study was set-up to focus on selection of a particular ZnO-NP dose that will kill pathogens without harming macrophages. The present study was designed to address a critical issue that has to be carefully taken into account to understand the potential toxicity on host cells, where high doses of ZnO-NPs are required to achieve desired therapeutic effects. First, the cytotoxic effect of ZnO-NPs on mouse macrophages was determined by MTT assay, which relies on the fact that metabolically active cells reduce MTT to purple formazan. Macrophages were treated with different concentrations of ZnO-NPs for 24h and the formation of formazan was measured at 570 nm. As shown in Fig 4. 2, A, approximately 60% reduction in cell viability (P ≤ .001) was observed at 80 µg/ml concentration, while treatment with 100 µg/ml ZnO-NP concentration approximately 80% cell deaths was observed (P ≤ .001). No significant A B difference in cell viability was observed up to 60 µg/ml concentration. Microscopic observation of monolayer macrophages also showed dose dependent disintegrated cell morphology and cellular extensions (Fig 4.2, B) . Cell viability was also determined by staining the cells with calcein AM, which is a non-fluorescent compound that permeates intact live cells. The hydrolysis of calcein AM by intracellular esterases produce calcein, a strongly fluorescent compound that is well-retained in the cell cytoplasm. Consistent with the MTT data, a dose dependent decrease in the number of live cells (green stain) and nuclear integrity as determined by DAPI staining (blue stain) was observed (Fig 4.2, C ). Based on above results, 60 µg/ml concentration was determined as non-toxic, 75 µg/ml as LD50 and 100 µg/ml as toxic dose. Hence, to compare the in vitro toxicity effects; in most casesa non toxic, the LD50, and a severely toxic dose response was examined. 
ZnO-NP treatment inhibits migration of macrophages
One of the consequences of toxicity is the inhibition of cellular migration. Therefore, wound healing assay was performed to determine whether ZnO-NPs inhibit cellular migration. For this, macrophages were treated with 60, 75, and 100 μg/ml doses of ZnO-NPs for 24 h. After the incubation, cells were washed, replaced with fresh media and further incubated for 48 h.
Untreated and 60 µg/ml dose treated macrophages were found to heal the wound, whereas cells treated with 75 and 100 µg/ml of ZnO-NPs failed to migrate after 48 h of incubation indicating that treatment with higher doses of ZnO-NPs inhibit cell migration (Fig 4.3) . Wounds were created by scrapping the cells followed by treatment with 60, 75, and 100 mg/ml of ZnO-NPs for 24 h. Then the cells were allowed to heal after addition of the fresh media without ZnO-NPs for 48 h.
ZnO-NP treatment induces oxidative stress by decreasing the activities of superoxide radical scavenging enzymes in macrophages
The induction of cellular oxidative stress responses has been shown to be responsible for cytotoxicity effects (Wiseman et al; 1996) . Therefore, the levels of intracellular toxic radicals and activities of oxidative stress scavenging enzymes such as catalase and SOD were compared in ZnO-NP treated and untreated macrophages. First the level of O2 was determined by DHE staining. As shown in Fig 4. 4, A, a dose dependent significant increase in the level of O2 was observed in ZnO-NP-treated macrophages after 24 h. The production of fluorescent DCF in the presence of intracellular ROS and cellular esterases (Carter et al; 1994, Rota et al; 1999) . The percentage of O2 and ROS production is calculated by determining the percentage of cells positive for DHE and DCFH-DA stain, respectively. A significant increase in O2 were observed in 100 µg/ml ZnO-NP-treated macrophages (15.8%)
as compared with 60 µg/ml (8.0%) and untreated (1.4%) cells (Fig 4.4, A) . Similarly, the elevated level of ROS production was observed in 100 µg/ml treated macrophages (6.2%) when compared with 60 µg/ml (2.3%) and untreated (1.6%) cells (Fig 4.4, B) .
O2
̅ are converted to H2O2 in the presence of SOD (Fukai et al; 2011) . Therefore SOD was measured in treated, untreated and zymosan-treated cells. Zymosan is known to stimulate ROS production in macrophages (Zhao et al; 2013) . The amount of peroxynitrite (ONOO ̅ )
formed is quantified by the addition of Griess reagent. The absorbance read is inversely proportional to the level of SOD (Pattichis et al; 1994) . As shown in Fig 4. 4, C, treatment with 100 µg/ml ZnO-NPs showed more ONOO ̅ formation, which implicates lower level of SOD, as compared with untreated, 60 µg/ml ZnO-NP and zymosan treated cells. The catalase activity was also found to be significantly decreased in 100 µg/ml ZnO-NP-treated macrophages as compared with untreated, 60 µg/ml ZnO-NP and zymosan-treated cells (Fig   4.4, D) . Collectively, the data suggest that the increased cellular toxicity is due to enhanced ROS production and decreased activities of oxidative stress scavenging enzymes. (D), Activity of catalase was determined by measuring the decomposition of H2O2 as described in the method section. Experiments were performed in triplicates, results are shown mean ± SD; **P ≤ .01; ***P ≤ .001.
ZnO-NP treatment induced apoptosis and autophagy in macrophages
Apoptosis is the major form of program cell death (PCD) mechanism in eukaryotic cells. To further understand the mechanism of enhanced cytotoxicity by ZnO-NPs, we examined NP effects on apoptosis in macrophages. Macrophages were treated with 100 µg/ml ZnO-NPs and analysed for apoptosis by annexin V-FITC and propidium iodide (PI) staining. A significant induction of apoptosis was observed at 100 µg/ml concentration (Fig 4.5, A) . A characteristic event of apoptosis is the proteolytic cleavage of poly (ADP-ribose) polymerase (PARP). Caspase-3 and -7 cleave the 116-kDa form of PARP to generate 85 and a 24 kDa fragments (Kaufmann et al.,1993) . Western blot analysis also showed a time dependent cleavage of PARP at 75 µg/ml ZnO-NP concentration, whereas no such effect was observed C D in untreated cells (Fig 4.5, B) . These results show that ZnO-NPs induce PARP mediated apoptosis in macrophages.
Another mechanism of PCD is associated with the appearance of autophagosomes and depends on autophagy proteins. One of the hallmarks of autophagy is the induction of microtubule associated protein 1 light chain 3 (LC3) .The cytosolic 18-kDa LC3 (also termed LC3-I) form is converted to the autophagosome-associated 16-kDa LC3-II form. The conversion of LC3-I to LC3-II is considered a reliable marker of autophagy (Xie et al., 2010) .
Therefore the expression of LC3-II was examined in macrophages treated with ZnO-NPs (75 µg/ml) for 24 h. Western blot analysis indicated significant increase in the level of LC3-II in treated macrophages as compared to control cells (Fig 4.5, C) . This was further corroborated by fluorescence microscopic studies using LC3 specific antibodies. As shown in (Fig 4. 
Mitochondrial membrane potential analysis
Intracellular accumulation of ROS alters mitochondrial membrane permeability, which affect mitochondrial membrane potential. Therefore, the changes in mitochondrial membrane potential of macrophages in response to ZnO-NP treatment were determined. The mitotracker red dye stained the mitochondria bright red in untreated and 60 µg/ml treated cells (Fig 4.6 ).
In contrast, no such staining was observed in 100 µg/ml ZnO-NP treated cells implying that treatment with higher doses of ZnO-NPs disintegrate mitochondrial membrane potential, which failed to accumulate mitotracker red within the mitochondria. 
Genotoxicity of ZnO-NPs
ZnO-NP treatment induces genomic instability in macrophages
Many reports have suggested that metallic NPs and oxidative stress induce host cell DNA damage (AshaRani et al; 2009, Pizarro et al; 2009) . Therefore, the chromosomal stability in macrophages after treatment with ZnO-NPs for 24 h was evaluated. DNA strand break, micronuclei formation, chromosomal segregation anomaly and nuclear fragmentation are considered as hallmarks of chromosomal instability (Mohanty et al; 2013) . First, the nuclear integrity was determined by DAPI staining after the treatment of cells with 60 and 100 µg/ml doses of ZnO-NPs for 24 h. An intact nucleus was observed in untreated and 60 µg/ml treated cells (Fig 4.7, A) . However, a prominent nucleus shrinkage and fragmentation were observed in 75 and 100 µg/ml ZnO-NP-treated cells, respectively (Fig 4.7, A) . Next, the effect of ZnONPs on DNA damage was determined by comet assay, in which the length of the tail increases with the extent of DNA damage. Treatment with 100 µg/ml ZnO-NPs showed a significant increase in comet like tail length in comparison to untreated, 60 µg/ml and 100 µg/ml+ NAC treated cells (Fig. 4.7 , B and C). Micronuclei formation was also studied in cytokinesis blocked cells after treatment with 60, 75, 100 µg/ml ZnO-NP doses and 100 µg/ml ZnO-NP plus NAC. Under each condition a total of 1000 bi-nucleated cells were analyzed for detecting micronuclei frequency. The extent of DNA damage was significantly higher in cells treated with 75 and 100 µg/ml ZnO-NP doses, in which significant numbers of micronuclei were formed as compared with untreated and 60 µg/ml dose treated cells, whereas addition of antioxidant drug NAC reduced the DNA damage induced after treatment with 100 µg/ml dose of D) . Moreover, other nuclear anomalies such as nuclear bud formation were also observed at 100 µg/ml ZnO-NP dose (Fig. 4.7, D) . Notably, no such events were observed in untreated, 60 and 100 µg/ml ZnO-NP+NAC treated cells. 
Clastogenicity of ZnO-NPs
ZnO-NP induces chromosomal instability in macrophages
Chromosomal segregation data revealed well segregated and intact chromosomes in untreated, 60 and 100 µg/ml ZnO-NPs with NAC-treated cells. In contrast, chromosomes appeared fragmented, which depict chromosomal aberrations, at 100 µg/ml ZnO-NP dose (Fig 4.8, A) .
ZnO-NP treatment showed reduced DNA repair efficacy in macrophage cells
The effect of ZnO-NPs on DNA repair mechanism was also determined. For this, the expression level of two DNA repair proteins, DNA polymerase b and flap endonuclease 1 (Fen1) was checked. These proteins play crucial role in base excision repair pathway. As shown in Fig 4.8, B , the expression of Pol β and Fen 1 was downregulated in 50 µg/ml treated cells when compared with 25 µg/ml ZnO-NP-treated macrophages, whereas addition C D of NAC in 50 µg/ml treated cells up regulated the expression of both proteins confirming that the reduction of DNA repair capacity was due to the oxidative stress induced by ZnO-NPs.
ZnO-NP induced F-actin depolymerization
The actin cytoskeleton in eukaryotes is essential for cell migration. The morphological changes and physical forces that occur during migration are generated by a dynamic filamentous actin (F-actin) cytoskeleton. Since distorted cell morphology and inhibition of cell migration were observed in ZnO-NP treated cells, therefore, the effect of ZnO-NPs on Factin architecture was studied. Macrophages treated with 75 and 100 µg/ml concentration of ZnO-NPs appeared rounded in shape, indicating loss of actin structure (Fig 4.2, B) . This was further confirmed by actin-specific rhodamine-phalloidin staining. As shown in Fig 4. 8, C
(lower panel), treatment with 75 and 100 µg/ml of ZnO-NPs degraded the F-actin structure, whereas an intact F-actin structure was observed in untreated and 60 µg/ml ZnO-NP-treated macrophages. However, treatment with NAC inhibited actin depolymerisation induced by ZnO-NPs (Fig 4.8, C , right panel).
Quantitative analysis of F-actin polymerization was also performed using fluorescence-based assay. In this assay, fluorescence of rhodamine phalloidin increases after binding to actin filaments. A dose dependent reduction in rhodamine phalloidin fluorescence was observed in ZnO-NP-treated macrophages when compared with untreated (control) macrophages, indicating that the quantity of F-actin decreased drastically in cells treated with higher doses of ZnO-NPs (Fig 4.8, D ).
ZnO-NP treatment causes irreversible disruption of actin microfilament network in macrophages
To check whether the disruption of actin filaments by ZnO-NPs is an irreversible phenomenon, macrophages were treated with 60, 75, and 100 µg/ml of ZnO-NPs for 24 h.
After the incubation, cell media was replaced with fresh medium devoid of ZnO-NPs and then the cells were further incubated for another 48 h followed by staining with rhodamine phalloidin. As shown in Fig 4. 8, E, actin filaments remained disintegrated even after depletion of ZnO-NPs from the medium indicating that 100 µg/ml concentration of ZnO-NP caused irreversible actin damage. The degradation of actin was also confirmed by western blot analysis using anti-β-actin antibodies. A dose-dependent degradation of β-actin was observed in ZnO-NP-treated macrophages, whereas the level of another cytoskeleton protein β-tubulin remains unchanged indicating that ZnO-NPs specifically degrades β-actin (Fig 4.8,   F ). Flow cytometry analysis of FITC-conjugated ZnO-NPs showed that these particles are actively endocytosed by macrophages. But the treatment of 100 µg/ml of ZnO-NPs showed reduced endocytosis efficiency. This may be due to the actin filament degradation which ultimately inhibit the endocytosis process of the macrophages.
ZnO-NP treatment arrest cell cycle progression
Previous studies have shown that apoptosis and oxidative stress may inhibit protein synthesis and arrest the cell cycle (Li et al; 2009) . Significantly higher cell cycle arrest at the G0/G1 transition phase (55.4%) was observed when the cells were treated with 100 µg/ml ZnO-NP (Fig 4. 9, G), while untreated and 60 µg/ml ZnO-NP-treated cells showed normal cell-cycle progression. These results indicate that treatment with toxic doses of ZnO-NPs arrest cell cycle progression, which may lead to cell apoptosis. 
Treatment with toxic dose of ZnO-NPs decrease mice survival
In order to obtain an in vivo insight of ZnO-NP toxicity, mice were fed orally with 200 and 500 mg/kg body weight of ZnO-NPs, which according to previously published reports were considered as non-toxic and toxic doses, respectively (Esmaeillou et al; 2013; Sharma et al; H 2012) . To evaluate that the cytotoxic and genotoxicity effects are due to oxidative stress, an antioxidant drug NAC was administered followed by the administration of ZnO-NPs.
Symptoms of toxicity such as loss of body weight and movement restriction were observed in ZnO-NP-treated mice. As shown in the Fig 4. 9, A, approximately 20 and 40% reduction in mice survival was observed in 200 and 500 mg/kg body weight treated mice, respectively; whereas administration of NAC in 500 mg/kg body weight treated mice increased the mice survival. It is known that ZnO-NP has the potential to induce inflammation due to activation of oxidative stress. In the previous chapter it has been shown that ZnO-NPs induce intracellular ROS production in human monocytic cells (Pati et al; 2014) . Therefore, the formation of inflammatory cells in response to ZnO-NP treatment in mice was checked. No significant differences in neutrophil, eosinophil, and lymphocyte cell numbers were observed on day 1, whereas a significant increase in neutrophils and a moderate decrease in lymphocytes were observed on day 6 in ZnO-NP treated mice (Fig 4.9, B) . (Fig 4.11, B) .
In contrast to that of the untreated and ZnO-NP with NAC-treated group of mice, kidneys 
DISCUSSION:
In recent years, owing to their ever increasing clinical (Cheng et al; 2011; Emerich et al; 2010) and therapeutic applications (Zhang et al; 2008) the exposure to NPs is also increasing. In eukaryotic cells, the actin cytoskeleton is mainly responsible for maintenance of cellular architecture and controls cellular migration (Le Clainche et al; 2008) . Within the cells, actin is present in 2 forms: Globular actin (G-actin) and filamentous actin (F-actin).
Among them, F-actin is primarily involved in crucial cellular processes like cell division, migration, and endocytosis. Endocytotic pathways consist of phagocytosis and pinocytosis, which includes 4 types of uptake pathways such as clatherin-mediated (receptor specific), caveolae (hydrophobic invaginations of plasma membrane), AND macropinocytosis. Both caveolae and macropinocytosis mediated uptake require intact actin cytoskeleton (Patron et al; 1994) . Previously, silver NPs were also shown to induce the loss of btubulin and F-actin (Xu et al; 2013) . ZnO-NP treatment also resulted in a dose-dependent degradation of actin filaments and that the effect was irreversible. The data showed that ZnO-NP treatment resulted in a drastic decrease in F-actin levels, whereas the levels of other housekeeping protein b-tubulin remained unchanged. Further, the data showed that treatment with 100 µg/ml dose reduced the uptake of ZnO-NPs, which corroborated the fact that actin depolymerization reduced the endocytosis. It has been shown that there is a tight regulatory interaction between cytoskeleton signaling during the cell cycle progression and mitotic Previously, it has been reported that ZnO-NPs exposure collectively induced apoptosis and autophagy in macrophage cells (Roy et al; 2014) . Thus, the present study provided evidences that ZnO-NP treatment-induced apoptosis and autophagy mechanisms, which reduced the viability of macrophages.
The induction of oxidative stress responses have been shown to induce apoptosis (Battisti et al; 2004) . Indeed, treatment with ZnO-NPs induced production of O2 -and ROS levels, while activities of oxidative stress scavenging enzymes such as SOD and catalase were found to be significantly less when compared with untreated cells. Under physiological conditions, SOD converts O2 -into H2O2, which is further converted into H2O and O2 by catalase. Hence, the increased O2 -level could be due to inhibition of SOD and catalase activities. Due to inhibition of oxidative stress scavenging enzymes the level of O2 -increased, which result in enhanced oxidative stress responses. Moreover, more production of peroxynitrite in ZnO-NP treated cells was observed. In living organisms, O2 -is scavenged by SOD. O2̅ interacts with NO to form peroxynitrite. Therefore, due to low SOD activity more O2̅ is available for interaction with NO, which led to increased production of peroxinitrite in ZnO-NP treated cells. N-acetyl-L-cysteine was known to protect the cells from ROS induced cytotoxicity by enhancing the synthesis of glutathione (GSH) (Zhang et al; 2011) . Treatment with NAC reduced ZnO-NP-induced cytotoxicity against macrophages.
The main consequence of oxidative stress is the DNA damage, which can result in genomic instability and lead to cell death (Wiseman et al; 1996) .The ZnO-NP-treated macrophages displayed severe aberrations in chromosomal integrity, micronuclei formation, nuclear bud formation, comet tail formation, and nuclear fragmentation, which are biomarkers of genotoxic events and genomic instability (Mohanty et al; 2013) . It is wellestablished that comet tail is formed due to DNA strand breaks. Micronuclei originate from dysfunctional DNA repair mechanism and acentric chromosome fragments or whole chromosomes that fail to be included in the daughter nuclei during mitosis due to the chromosomal anomaly during the segregation process (Fenech; 2006) . It has been hypothesized that the observed comet tail formation, micronuclei formation and aberrations in chromosomal and nuclear integrity were due to DNA breaks or dysfunctional proteins involved in chromosomal segregation due to induced oxidative stress. Interestingly, nuclear bud formation in ZnO-NP-treated macrophages was also observed. The Nucleoplasmic bridge is caused by misrepair of DNA breaks and is also associated with micronuclei formation due to failure in DNA repair mechanism (Fenech et al; 2011) . Nuclear buds are formed due to nuclear membrane entrapment of DNA that has been left in the cytoplasm after nuclear division. It is also reported that micronuclei may also be formed by a budding process (Fenech et al; 2011) . Treatment with NAC reduced the marked genomic instability induced by the ZnO-NP even at 100 µg/ml dose. It was due to the antioxidative activity of NAC which protect the cells and eventually decreased genotoxicity. DNA repair enzymes have a crucial role in gene stability which continuously monitor chromosomes to correct damaged nucleotide residues generated by exposure to carcinogens and cytotoxic compounds. The pathway mechanisms involve the excision of altered bases by DNA glycosylases, incision at abasic sites by endonuclease, short patch gap filling by DNA polymerase and sealing of the breaks in phosphate sugar back bone of DNA by DNA ligase (Lindahl; 1976) . Among them, DNA polymerase β and flap endonuclease-1 have major role in both single nucleotide and long patch base excision repair pathway mechanisms (Dianov et al; 1999, Kim et al; 1998) . Previously, it was reported that the absence of DNA damage repair gene caused cell cycle arrest and apoptosis (Deng et al; 2003) . From the genomic repair data, it was observed that the ZnO-NP-treated cells showed reduced DNA damage capacity. Further, it was found that NAC-treated cells have more DNA repair efficiency which showed more expression of both the DNA repair protein.
Altogether, these studies demonstrate that ZnO-NP treatment caused oxidative stress mediated chromosomal instability in macrophages.
Mitochondria play an important role in apoptosis, via the intrinsic apoptotic program.
An initial step for activation of the intrinsic apoptotic pathway is the depolarization of the mitochondrial membrane due to formation transition pores resulting from an elevation in ROS production (Hirsch et al; 1997) . The fluorescence microscopy data confirmed significant mitochondrial membrane damage as no co-localization of Mitotracker red and calcein-AM was observed in ZnO-NP treated macrophages. Moreover, the data showed cell cycle arrest in G0 phase. It has been shown that cell cycle arrest in G0 phase affects protein synthesis (Hahm and Singh, 2007) due to which cells are driven towards apoptosis mediated death pathway.
Foodborne infections are a major concern (Kotloff et al; 1999) . Several studies have addressed the applications of ZnO-NPs in food processing due to their potential antibacterial activity against foodborne pathogens (Xie et al; 2011) . Therefore, food packaging and dermatological applications of ZnO-NPs pose a risk of direct ingestion. Moreover, these NPs may gain entry into the gastrointestinal tract after their accidental release into the environment. Therefore to study their in vivo toxicological effects mice were administered orally with different doses of ZnO-NPs. Invivo toxicity by metallic NP through gastrointestinal route has already been reported. Ingestion of metallic NPs induced bluish pigmentation of skin and toxicity in kidney and liver (Bergin et al; 2013) .
NAC is a membrane permeable, cysteine precursor which does not require active transport for its intracellular delivery. Inside the cells, it undergoes hydrolysis and delivers cysteine, which is an important precursor of antioxidant GSH. Hence, NAC is a free radical scavenging agent that protects the cells from oxidative stress by maintaining the intracellular GSH level (Arakawa et al; 2007) . Importantly, it has been reported that, NAC reduced oxidative stress in workers exposed to lead by stimulating GSH synthesis (Kasperczyk et al; 2013) .
Oxidative stress mostly targets DNA and induces base modifications, DSBs and lesion formation (Girard et al; 1997) . Previously, it was shown that oral administration of ZnO-NPs to mice induced oxidative stress and was located inside the cytoplasm and nucleus (Shrivastava et al; 2014) . In this study, the in vivo studies showed decrease in mice survival, severe DNA damage and higher number of aberrant cells in both blood and bone marrow cells after exposure to higher doses of ZnO-NPs. The appearance of cH2AX foci indicated that DNA damage was due to double stranded breaks. Previously, it was reported that oral administration of ZnO-NP in mice induced apoptosis and DNA damage in liver cells (Li et al; 2012; Sharma et al; 2012) . The decrease in mice survival could be due ZnO-NP induced damage to liver, spleen, kidneys organs. Moreover, hyperinflammatory responses observed in these organs could be a result of massive infiltration of inflammatory cells to these organs.
Interestingly, due to the neutralization efficacy of NAC against oxidative stress, increased percentage of mice survival, reduced genetic instability, less inflammation, and increased DNA repair efficacy were observed.
